Of these 68 colorectal programs using a preoperative CCD, 98.5% administered a beverage to patients without diabetes, 79.7% administered a beverage to patients with diabetes not taking insulin, and 60.9% administered a beverage to patients with diabetes taking insulin (p < 0.05). This evidence concerns the gene INS and diabetes mellitus.